Background. Ductal carcinoma in situ (DCIS) of the male breast is an uncommon disease, accounting for approximately 7% of all male breast carcinomas. Compared with invasive carcinomas of the breast, the prognosis associated with DCIS in men is excellent; however, clinical features, pathology, and tr
Limits of resection for ductal carcinoma in situ
โ Scribed by Osteen, Robert T.
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 47 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: The natural history of patients with intraductal carcinoma (dcis) and microinvasion is poorly defined, and the clinical management of these patients, with particular reference to management of the axilla, has been controversial. previous studies of this lesion have used varied and/or
Ductal carcinoma in situ (DCIS) was a relatively uncommon disease process when we relied on palpation to detect breast lesions. With the advent of more widespread mammography screenings, the surgeon is faced with a welcome opportunity to prevent cancer by dealing with a precursor lesion. Discovering
A case report is presented of a woman with recurrent DCIS occurring several years following a total mastectomy, the diagnosis of which was aided by a subpectoral saline implant. A discussion of factors associated with recurrence and a review of the literature is provided. A role for selective use of
## Background: The treatment of ductal carcinoma in situ (dcis) remains controversial, particularly in regard to the selection of patients who may be appropriately treated with wide excision alone. to help identify such patients, the authors assessed prognostic factors for local recurrence in patie
## Presented at the Consensus Conference on the Because it has been documented that only a minority of patients Classification of Ductal Carcinoma In Situ, Phildevelop invasive cancer after excision of DCIS, some physicians have adelphia, Pennsylvania, April 25-28, 1997. been treating selected pat